V E P P Lemmens
Overview
Explore the profile of V E P P Lemmens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
2334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaplan Z, van Leeuwen N, van Klaveren D, Eijkenaar F, Visser O, Posthuma E, et al.
ESMO Open
. 2025 Jan;
10(2):104152.
PMID: 39889323
Background: Acute myeloid leukemia (AML) requires specialized care, particularly when administrating intensive remission induction chemotherapy (ICT). High-volume hospitals are presumed more adept at delivering this complex treatment, resulting in better...
2.
Schilte-Praagman J, van Dijk B, Brands M, Frank M, Lemmens V, Merkx M
Ned Tijdschr Tandheelkd
. 2024 Mar;
131(3):121-126.
PMID: 38440819
For years, cancer has been one of the diseases that causes the greatest disease burden in the Netherlands. Cancer does not only have a huge impact on patients and their...
3.
Schuurman M, Elferink M, Verhoef C, de Hingh I, Lemmens V
Eur J Surg Oncol
. 2022 Jun;
48(12):2558-2564.
PMID: 35662530
Background: With the introduction of cytoreductive surgery with intraperitoneal chemotherapy and the development of new systemic anti-cancer agents, the treatment of colorectal cancer (CRC) patients with peritoneal metastases has changed....
4.
van Herwaarden Y, Madani A, van der Post R, Lemmens V, Nagtegaal I
Br J Surg
. 2021 Sep;
108(11):e373-e374.
PMID: 34508554
No abstract available.
5.
Meijer L, Verhoeven R, de Hingh I, van de Wouw A, van Laarhoven H, Lemmens V, et al.
Clin Exp Metastasis
. 2021 Jan;
38(2):231-238.
PMID: 33515369
Patients with carcinoma of unknown primary (CUP) present with metastatic disease without an identified primary tumour. The unknown site of origin makes the diagnostic work-up and treatment challenging. Since little...
6.
Walraven J, Desar I, Hoeven van der J, Aben K, Hillegersberg van R, Rasch C, et al.
Eur J Cancer
. 2019 Sep;
121:85-93.
PMID: 31563730
Introduction: For optimal oncological care, it is recommended to discuss every patient with cancer in a multidisciplinary team meeting (MDTM). This is a time consuming and expensive practice, leading to...
7.
Giesen L, van Erning F, Vissers P, Maas H, Rutten H, Lemmens V, et al.
Eur J Surg Oncol
. 2019 Jun;
45(10):1882-1886.
PMID: 31202571
Introduction: Hospital of diagnosis is shown to have an impact on the probability of undergoing a resection in different types of gastrointestinal cancer. The aim of this study was to...
8.
Bos A, Kortbeek D, van Erning F, Zimmerman D, Lemmens V, Dekker J, et al.
Eur J Surg Oncol
. 2019 May;
45(9):1575-1583.
PMID: 31053476
Background: Worse prognosis in elderly colorectal cancer (CRC) patients may be cancer or treatment related, or death from other causes. This population-based study aimed to compare survival among non-metastatic CRC...
9.
Claassen Y, Bastiaannet E, Van Eycken E, Van Damme N, Martling A, Johansson R, et al.
Eur J Surg Oncol
. 2019 Apr;
45(8):1396-1402.
PMID: 31003722
Background: Decreased cancer specific survival in older colorectal patients is mainly due to mortality in the first year, emphasizing the importance of the first postoperative year. This study aims to...
10.
van der Werf L, Eshuis W, Draaisma W, van Etten B, Gisbertz S, van der Harst E, et al.
J Gastrointest Surg
. 2019 Mar;
23(12):2327-2337.
PMID: 30820797
Background: Radical gastrectomy is the cornerstone of the treatment of gastric cancer. For tumors invading the pancreas, en-bloc partial pancreatectomy may be needed for a radical resection. The aim of...